BR0114896A - Preparação contendo nateglinida, e, método para produzir a mesma - Google Patents

Preparação contendo nateglinida, e, método para produzir a mesma

Info

Publication number
BR0114896A
BR0114896A BR0114896-6A BR0114896A BR0114896A BR 0114896 A BR0114896 A BR 0114896A BR 0114896 A BR0114896 A BR 0114896A BR 0114896 A BR0114896 A BR 0114896A
Authority
BR
Brazil
Prior art keywords
producing
same
nateglinide
preparation containing
containing nateglinide
Prior art date
Application number
BR0114896-6A
Other languages
English (en)
Inventor
Nobutaka Ninomiya
Chisato Makino
Akira Yabuki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of BR0114896A publication Critical patent/BR0114896A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PREPARAçãO CONTENDO NATEGLINIDA, E, MéTODO PARA PRODUZIR A MESMA". A presente invenção expõe, como uma preparação de liberação imediata, útil como um antidiabético, uma preparação contendo nateglinida, que compreende nateglinida como um ingrediente ativo, em que a nateglinida é amorfa.
BR0114896-6A 2000-10-24 2001-10-23 Preparação contendo nateglinida, e, método para produzir a mesma BR0114896A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000324373 2000-10-24
PCT/JP2001/009291 WO2002034254A1 (fr) 2000-10-24 2001-10-23 Preparations contenant du nateglinide

Publications (1)

Publication Number Publication Date
BR0114896A true BR0114896A (pt) 2003-08-12

Family

ID=18801918

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114896-6A BR0114896A (pt) 2000-10-24 2001-10-23 Preparação contendo nateglinida, e, método para produzir a mesma

Country Status (17)

Country Link
US (2) US7605180B2 (pt)
EP (1) EP1334720B1 (pt)
JP (3) JP4501054B2 (pt)
KR (1) KR100869039B1 (pt)
CN (1) CN100352432C (pt)
AT (1) ATE406885T1 (pt)
AU (1) AU2001295999A1 (pt)
BR (1) BR0114896A (pt)
CA (1) CA2426263C (pt)
DE (1) DE60135674D1 (pt)
DK (1) DK1334720T3 (pt)
ES (1) ES2307653T3 (pt)
MX (1) MXPA03003685A (pt)
PT (1) PT1334720E (pt)
RU (1) RU2271805C2 (pt)
TW (1) TWI283573B (pt)
WO (1) WO2002034254A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1258249B1 (en) * 1999-12-28 2005-11-23 Ajinomoto Co., Inc. Oral preparations for diabetes
BR0109336A (pt) * 2000-03-17 2003-06-24 Ajinomoto C0 Inc Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
MXPA03003483A (es) * 2000-10-18 2003-07-14 Ajinomoto Kk Procedimiento para la preparacion de acilfenilalaninas.
RU2273629C2 (ru) * 2000-10-18 2006-04-10 Адзиномото Ко., Инк. Способы получения кристаллов натеглинида
DK1334964T3 (da) * 2000-10-24 2007-09-24 Ajinomoto Kk Fremgangsmåde til fremstilling af nateglinidkrystaller med B form
MXPA03003686A (es) * 2000-10-24 2004-01-26 Ajinomoto Kk Preparaciones hidrofilas de farmaco que contienen nateglinida.
ATE406885T1 (de) * 2000-10-24 2008-09-15 Ajinomoto Kk Nateglinid enthaltende präparate
JP4833464B2 (ja) * 2001-11-28 2011-12-07 大正製薬株式会社 難溶性薬物含有固形製剤の製造方法
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
KR100882156B1 (ko) 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005020979A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions of nateglinide
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
WO2005094812A1 (ja) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
KR20070040389A (ko) * 2004-08-10 2007-04-16 아지노모토 가부시키가이샤 쓴 맛이 감소된 나테글리니드 함유 제제
EP1891971A4 (en) * 2005-01-31 2010-02-03 Ajinomoto Kk MEDICAL COMPOSITION USING HYPERGLY CRAB MEDICAMENT TO TREAT OR TREAT GLUCOSE-INTOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE AND HYPERINSULINEMIA
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
JP4463875B2 (ja) 2007-03-29 2010-05-19 第一三共株式会社 医薬組成物
TR200801178A2 (tr) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
CN101590063A (zh) * 2008-05-26 2009-12-02 中国科学院上海生命科学研究院 丹参酮iia在制备治疗肥胖及胰岛素抵抗的药物中的应用
HUE031059T2 (en) 2010-03-19 2017-06-28 Daiichi Sankyo Co Ltd Procedure for improving anticoagulant administration
WO2011157986A1 (en) 2010-06-14 2011-12-22 Cipla Limited A process for the preparation of nateglinide
BR112014002397B1 (pt) 2011-08-10 2021-08-03 Daiichi Sankyo Company, Limited Formulação sólida na forma de tablete ou cápsula contendo derivado de diamida
CN102813636B (zh) * 2012-08-28 2014-04-16 西南药业股份有限公司 那格列奈片及其制备方法
CA2918570A1 (en) * 2013-07-22 2015-01-29 Sandoz Ag Formulations containing amorphous dapagliflozin
JP6647902B2 (ja) * 2015-10-30 2020-02-14 株式会社ファンケル 徐放性顆粒剤
KR20240025990A (ko) * 2022-08-19 2024-02-27 주식회사 스카이테라퓨틱스 무정형 수니티닙, 그 제조방법 및 이를 포함한 의약 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
JPH0415221A (ja) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd ポリカーボネートの製造法
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
JP2508949B2 (ja) * 1991-07-30 1996-06-19 味の素株式会社 Ｎ−（トランス−４−イソプロピルシクロヘキシルカルボニル）−ｄ−フェニルアラニンの結晶及びその製造法
ES2364145T3 (es) 1996-11-15 2011-08-25 Ajinomoto Co., Inc. Composición de nateglinida en comprimidos.
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
JP2002509103A (ja) * 1998-01-20 2002-03-26 アプライド・アナリティカル・インダストリーズ，インコーポレイテッド 経口液体組成物
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
EP1258249B1 (en) 1999-12-28 2005-11-23 Ajinomoto Co., Inc. Oral preparations for diabetes
BR0109336A (pt) 2000-03-17 2003-06-24 Ajinomoto C0 Inc Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
RU2273629C2 (ru) 2000-10-18 2006-04-10 Адзиномото Ко., Инк. Способы получения кристаллов натеглинида
MXPA03003483A (es) 2000-10-18 2003-07-14 Ajinomoto Kk Procedimiento para la preparacion de acilfenilalaninas.
DK1334964T3 (da) 2000-10-24 2007-09-24 Ajinomoto Kk Fremgangsmåde til fremstilling af nateglinidkrystaller med B form
ATE406885T1 (de) * 2000-10-24 2008-09-15 Ajinomoto Kk Nateglinid enthaltende präparate
MXPA03003686A (es) 2000-10-24 2004-01-26 Ajinomoto Kk Preparaciones hidrofilas de farmaco que contienen nateglinida.
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제

Also Published As

Publication number Publication date
DE60135674D1 (de) 2008-10-16
CN100352432C (zh) 2007-12-05
MXPA03003685A (es) 2004-01-26
KR20030042027A (ko) 2003-05-27
EP1334720A4 (en) 2004-02-04
AU2001295999A1 (en) 2002-05-06
CA2426263C (en) 2010-05-25
JP5610165B2 (ja) 2014-10-22
JP2013028636A (ja) 2013-02-07
ES2307653T3 (es) 2008-12-01
CA2426263A1 (en) 2003-04-23
US7605180B2 (en) 2009-10-20
WO2002034254A1 (fr) 2002-05-02
US20040014815A1 (en) 2004-01-22
PT1334720E (pt) 2008-09-30
EP1334720A1 (en) 2003-08-13
US20090203791A1 (en) 2009-08-13
DK1334720T3 (da) 2009-01-19
EP1334720B1 (en) 2008-09-03
JPWO2002034254A1 (ja) 2004-08-26
ATE406885T1 (de) 2008-09-15
TWI283573B (en) 2007-07-11
RU2271805C2 (ru) 2006-03-20
KR100869039B1 (ko) 2008-11-17
JP4501054B2 (ja) 2010-07-14
CN1482903A (zh) 2004-03-17
JP2010100654A (ja) 2010-05-06

Similar Documents

Publication Publication Date Title
BR0114896A (pt) Preparação contendo nateglinida, e, método para produzir a mesma
BR0113494B1 (pt) processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida.
EP1401433A4 (en) CONSTANTLY CONFORMING ANALOGUES AS AGENTS AGAINST DIABETES AND AGAINST OBESITY, AND ASSOCIATED METHOD
GB0019283D0 (en) Organic compounds
NO20041567L (no) 1,8-nafthyridinderivater som antidiabetiske midler
PT698393E (pt) Agente de solubilizacao e preparacao para uso externo contendo o mesmo
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
USD442687S1 (en) Surgical tibial retractor tool
AU2001279664A1 (en) Endoparasiticidal agents for voluntary oral ingestion by animals
BR0114241B1 (pt) composição para desinfetar uma lente de contato, e método para desinfetar uma lente de contato.
ATE323674T1 (de) Orale antidiabetische wirkstoffe
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
DK1389213T3 (da) 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser
ITMI20000440A0 (it) Forme solide orali a rilascio controllato contenenti mesalazina come principio attivo
ZA200304928B (en) Medicament containing a polyamine as an active substance.
EE200200583A (et) (E)-N-(6,6-dimetüül-2-hepteen-4-ünüül)-N-metüül-1-naftaleenmetaanamiini (terbinafiin) valmistamise meetod
SE8000085L (sv) Cis och trans-3-aryloxi-4-hydroxipyrrolidiner och derivater derav
NO20034528D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
BR0107483A (pt) Processo para a preparação de um composto
BR9909756B1 (pt) processos para a preparação de 2-aril-hidrazino-succinonitrila e 3-(aril-hidrazono)propionitrila.
AU6576400A (en) Inactivated vaccine against feline calicivirus disease
BR0114931B1 (pt) processo para a preparação de álcool 4-metil-2,3,5,6-tetra-fluorobenzìlico, e, composto
WO2002024210A3 (en) Halogen compounds for use in medicine
CO4650114A1 (es) Atractor sexual para el escarbajo longicorne migdolus frya- nus westwood

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2277 DE 26/08/2014.